Evidence map›Paper›PMID 24336651›Full record

ArticleAmerican journal of physiology. Cell physiology2014

miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export.

Matthew B Hudson, Myra E Woodworth-Hobbs, Bin Zheng, Jill A Rahnert, Mitsi A Blount, Jennifer L Gooch, Charles D Searles, S Russ Price

Abstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 130 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Frontiers in veterinary science · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Epigenetics of Skeletal Muscle Atrophy.International journal of molecular sciences · 2024
    Review
  18. Review
  19. Review
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Matthew B HudsonRenal Division, Department of Medicine, Emory University, Atlanta, Georgia;
Myra E Woodworth-Hobbs
Bin Zheng
Jill A Rahnert
Mitsi A Blount
Jennifer L Gooch
Charles D Searles
S Russ Price
Emory University · USVeterans Health Administration · US

Funding

Nephrology Institutional Training Grant FLSA SupplementT32DK007656 · NIDDK · EMORY UNIVERSITY · PI SANDS, JEFF M, WALL, SUSAN MARIE · 1990 to 2020
$3.5M
Nutrition Sciences and HealthT32DK007734 · NIDDK · EMORY UNIVERSITY · PI RAMAKRISHNAN, USHA · 1997 to 2016
$2.5M
Calcineurin signaling, PGC-1 alpha and protein-energy wasting in kidney diseaseR01DK095610 · NIDDK · EMORY UNIVERSITY · PI PRICE, S. RUSS · 2012 to 2015
$1.3M
Modulation of Endothelial Cell Function by the Shear Stress-Responsive miR-155R01HL109559 · NHLBI · EMORY UNIVERSITY · PI SEARLES, CHARLES D · 2011 to 2014
$1.3M
Mechanisms of obesity-linked muscle atrophy and n-3 fatty acidsI01BX001456 · VA · VETERANS HEALTH ADMINISTRATION · PI PRICE, S. RUSS · 2013 to 2017
–
BLRD VA I01 BX001456NHLBI NIH HHS HL-109559NHLBI NIH HHS R01 HL109559NIDDK NIH HHS R01 DK-007656NIDDK NIH HHS R01 DK095610NIDDK NIH HHS T32 DK-007656NIDDK NIH HHS T32 DK007734
6 · The paper itself

Abstract

Skeletal muscle atrophy is prevalent in chronic diseases, and microRNAs (miRs) may play a key role in the wasting process. miR-23a was previously shown to inhibit the expression of atrogin-1 and muscle RING-finger protein-1 (MuRF1) in muscle. It also was reported to be regulated by cytoplasmic nuclear factor of activated T cells 3 (NFATc3) in cardiomyocytes. The objective of this study was to determine if miR-23a is regulated during muscle atrophy and to evaluate the relationship between calcineurin (Cn)/NFAT signaling and miR-23a expression in skeletal muscle cells during atrophy. miR-23a was decreased in the gastrocnemius of rats with acute streptozotocin-induced diabetes, a condition known to increase atrogin-1 and MuRF1 expression and cause atrophy. Treatment of C2C12 myotubes with dexamethasone (Dex) for 48 h also reduced miR-23a as well as RCAN1.4 mRNA, which is transcriptionally regulated by NFAT. NFATc3 nuclear localization and the amount of miR-23a decreased rapidly within 1 h of Dex administration, suggesting a link between Cn signaling and miR-23a. The level of miR-23a was lower in primary myotubes from mice lacking the α- or β-isoform of the CnA catalytic subunit than wild-type mice. Dex did not further suppress miR-23a in myotubes from Cn-deficient mice. Overexpression of CnAβ in C2C12 myotubes prevented Dex-induced suppression of miR-23a. Finally, miR-23a was present in exosomes isolated from the media of C2C12 myotubes, and Dex increased its exosomal abundance. Dex did not alter the number of exosomes released into the media. We conclude that atrophy-inducing conditions downregulate miR-23a in muscle by mechanisms involving attenuated Cn/NFAT signaling and selective packaging into exosomes.

Indexed as

AnimalsBiological TransportCalcineurinCalcium-Binding ProteinsCells, CulturedDexamethasoneDiabetes Mellitus, ExperimentalExosome Multienzyme Ribonuclease ComplexIntracellular Signaling Peptides and ProteinsMaleMiceMice, KnockoutMicroRNAsMuscle Fibers, SkeletalMuscle ProteinsMuscular AtrophyCalcineurinCalcium-Binding ProteinsDexamethasoneDSCR1 protein, mouseExosome Multienzyme Ribonuclease ComplexIntracellular Signaling Peptides and ProteinsMicroRNAsMirn23b microRNA, mouseMuscle ProteinsNFATC Transcription FactorsRNA, MessengerStreptozocintranscription factor NF-AT c3atrophycalcineuringene expressionglucocorticoidsmicroRNAskeletal muscle

Identifiers

PMID24336651
PMCPMC3948973
OpenAlexW2168020094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.